BACKGROUND:Global longitudinal systolic strain (GLS) is often reduced in aortic stenosis despite normal ejection fraction. The importance of reduced preoperative GLS on long-term outcome after aortic valve replacement is unknown. METHODS AND RESULTS: A total of 125 patients with severe aortic stenosis and ejection fraction >40% scheduled for aortic valve replacement were evaluated preoperatively and divided into 4 groups according to GLS quartiles. Patients were followed up for 4 years. The primary end points were major adverse cardiac events (MACEs) defined as cardiovascular mortality and cardiac hospitalization because of worsening of heart failure; the secondary end point was cardiovascular mortality. MACE and cardiac mortality were significantly increased in patients with lower GLS. Estimated 5-year MACE was increased: first quartile 19% (n=6) / second quartile 20% (n=6) / third quartile 35% (n=11) / fourth quartile 49% (n=15); P=0.04. Patients with increased age, left ventricular hypertrophy, and left atrial dilatation were at increased risk. In Cox regression analysis, after correcting for standard risk factors and ejection fraction, GLS was found to be significantly associated with cardiac morbidity and mortality. In a stepwise Cox model with forward selection, GLS was the sole independent predictor: hazard ratio=1.13 (95% confidence interval, 1.02-1.25), P=0.04. Comparing the overall log likelihood χ(2) of the predictive power of the multivariable model containing GLS was statistically superior to models based on EuroScore, history with ischemic heart disease, and ejection fraction. CONCLUSIONS: In patients with symptomatic severe aortic stenosis undergoing aortic valve replacement, reducedGLS provides important prognostic information beyond standard risk factors.
RCT Entities:
BACKGROUND: Global longitudinal systolic strain (GLS) is often reduced in aortic stenosis despite normal ejection fraction. The importance of reduced preoperative GLS on long-term outcome after aortic valve replacement is unknown. METHODS AND RESULTS: A total of 125 patients with severe aortic stenosis and ejection fraction >40% scheduled for aortic valve replacement were evaluated preoperatively and divided into 4 groups according to GLS quartiles. Patients were followed up for 4 years. The primary end points were major adverse cardiac events (MACEs) defined as cardiovascular mortality and cardiac hospitalization because of worsening of heart failure; the secondary end point was cardiovascular mortality. MACE and cardiac mortality were significantly increased in patients with lower GLS. Estimated 5-year MACE was increased: first quartile 19% (n=6) / second quartile 20% (n=6) / third quartile 35% (n=11) / fourth quartile 49% (n=15); P=0.04. Patients with increased age, left ventricular hypertrophy, and left atrial dilatation were at increased risk. In Cox regression analysis, after correcting for standard risk factors and ejection fraction, GLS was found to be significantly associated with cardiac morbidity and mortality. In a stepwise Cox model with forward selection, GLS was the sole independent predictor: hazard ratio=1.13 (95% confidence interval, 1.02-1.25), P=0.04. Comparing the overall log likelihood χ(2) of the predictive power of the multivariable model containing GLS was statistically superior to models based on EuroScore, history with ischemicheart disease, and ejection fraction. CONCLUSIONS: In patients with symptomatic severe aortic stenosis undergoing aortic valve replacement, reduced GLS provides important prognostic information beyond standard risk factors.
Authors: Abraham Sonny; Andrej Alfirevic; Shiva Sale; Nicole M Zimmerman; Jing You; A Marc Gillinov; Daniel I Sessler; Andra E Duncan Journal: Anesth Analg Date: 2018-05 Impact factor: 5.108
Authors: Andrea Sonaglioni; Gian Luigi Nicolosi; Michele Lombardo; Gian Franco Gensini; Giuseppe Ambrosio Journal: Int J Cardiovasc Imaging Date: 2020-10-30 Impact factor: 2.357
Authors: K Balderas-Muñoz; H Rodríguez-Zanella; J F Fritche-Salazar; N Ávila-Vanzzini; L E Juárez Orozco; J A Arias-Godínez; O Calvillo-Argüelles; S Rivera-Peralta; J C Sauza-Sosa; M E Ruiz-Esparza; E Bucio-Reta; A Rómero; N Espinola-Zavaleta; B Domínguez-Mendez; M Gaxiola-Macias; M A Martínez-Ríos Journal: Int J Cardiovasc Imaging Date: 2017-05-09 Impact factor: 2.357
Authors: Brian R Lindman; Qi Liu; Brian P Cupps; Pamela K Woodard; Eric Novak; Anna M Vatterott; Danielle J Koerner; Kevin Kulshrestha; Michael K Pasque Journal: J Card Surg Date: 2017-08 Impact factor: 1.620
Authors: R Dulgheru; J Magne; L Davin; A Nchimi; C Oury; L A Pierard; P Lancellotti Journal: Eur Heart J Cardiovasc Imaging Date: 2015-06-09 Impact factor: 6.875
Authors: E Mara Vollema; Tadafumi Sugimoto; Mylène Shen; Lionel Tastet; Arnold C T Ng; Rachid Abou; Nina Ajmone Marsan; Bart Mertens; Raluca Dulgheru; Patrizio Lancellotti; Marie-Annick Clavel; Philippe Pibarot; Philippe Genereux; Martin B Leon; Victoria Delgado; Jeroen J Bax Journal: JAMA Cardiol Date: 2018-09-01 Impact factor: 14.676